Inventor

Thierry Gallet

Inventor
Palaiseau, FR

Overview

13→
Patents
2000–2013
Patent span
Human necessities
Primary field (CPC A)

Patents· 13 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes19%
A01NPreservation of bodies of humans or animals or plants or parts thereof8%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
8,598,175'Heteroarylamide pyrimidone derivatives'20138,592,436'Arylamide pyrimidone derivatives'20138,198,287'Substituted heteroaryl pyridopyrimidone derivatives'20127,781,440'Use of substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives'20107,566,720'2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives'20097,462,621'Use of substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives as therapeutic agents'20087,388,005'Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders'20087,214,682'Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives'20077,001,902'4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof'20066,987,106'1,4-diazabicyclo[3.2.2]nonane-4-carboxylates and carboxamide derivates, production and use thereof in therapeutics'20066,974,819'2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo{1,2-a}pyrimidin-5(1H)one derivatives'20056,255,319'5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands'20016,143,761'2,3-dihydrofuro [3,2-.beta.]pyridin, preparation and application thereof in therapy'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2013Based in Palaiseau, FR· patent location history
2005–2010Patents assigned to MITSUBISHI PHARMA CORP (6)· patent assignee history
2006–2012Patents assigned to SANOFI AVENTIS (6)· patent assignee history
2012–2013Patents assigned to GALLET THIERRY (3)· patent assignee history
2012–2013Patents assigned to LOCHEAD ALISTAIR (3)· patent assignee history
2012–2013Patents assigned to SAADY MOURAD (3)· patent assignee history
2012Based in Paris, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MITSUBISHI PHARMA CORP62005–2010
SANOFI AVENTIS62006–2012
GALLET THIERRYself32012–2013
LOCHEAD ALISTAIR32012–2013
SAADY MOURAD32012–2013
Locations
LocationPatentsSpan
Palaiseau, FR122000–2013
Paris, FR12012